Literature DB >> 2221861

Mode of action of tubulozoles against Plasmodium falciparum in vitro.

A Dieckmann-Schuppert1, R M Franklin.   

Abstract

The mode of action of the tubulozole isomers, recently recognized as a new class of potential antimalarial agents, was investigated. Whereas neither glycolysis, protease activity, or nucleic acid biosynthesis was primarily affected, protein biosynthesis decreased soon after addition of the drug. Inhibitors of protein biosynthesis, however, did not show synergistic activity with tubulozole. Colcemid, on the other hand, had an effect on protein synthesis similar to that seen with the tubulozoles. Furthermore, combinations of the tubulozole isomers with compounds known to interact with tubulin inhibited malaria in a synergistic or antagonistic fashion. Therefore, the inhibition might be elicited by interaction with tubulin or some other component of the microtubules. This is remarkable insofar as only one of the tubulozole isomers affects mammalian cells by binding to tubulin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221861      PMCID: PMC171867          DOI: 10.1128/AAC.34.8.1529

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  A new ultrasensitive method for the determination of proteolytic activity.

Authors:  H Rinderknecht; M C Geokas; P Silverman; B J Haverback
Journal:  Clin Chim Acta       Date:  1968-08       Impact factor: 3.786

2.  Chloroquine inhibits the degradation of endocytic vesicles in human malaria parasites.

Authors:  A Yayon; H Ginsburg
Journal:  Cell Biol Int Rep       Date:  1983-11

3.  Effects of antibiotics on Plasmodium falciparum in vitro.

Authors:  T G Geary; J B Jensen
Journal:  Am J Trop Med Hyg       Date:  1983-03       Impact factor: 2.345

4.  A method for testing for synergy with any number of agents.

Authors:  M C Berenbaum
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

5.  The biochemical events of mitosis. I. Synthesis and properties of colchicine labeled with tritium in its acetyl moiety.

Authors:  L Wilson; M Friedkin
Journal:  Biochemistry       Date:  1966-07       Impact factor: 3.162

6.  The accumulation of lactic acid and its influence on the growth of Plasmodium falciparum in synchronized cultures.

Authors:  J W Zolg; A J Macleod; J G Scaife; R L Beaudoin
Journal:  In Vitro       Date:  1984-03

7.  The mitochondrion of Plasmodium falciparum visualized by rhodamine 123 fluorescence.

Authors:  A A Divo; T G Geary; J B Jensen; H Ginsburg
Journal:  J Protozool       Date:  1985-08

8.  Synchronization of Plasmodium falciparum erythrocytic stages in culture.

Authors:  C Lambros; J P Vanderberg
Journal:  J Parasitol       Date:  1979-06       Impact factor: 1.276

9.  Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture.

Authors:  A A Divo; T G Geary; J B Jensen
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

10.  Effects of tubulozole on the microtubule system of cells in culture and in vivo.

Authors:  G M Geuens; R M Nuydens; R E Willebrords; R M Van de Veire; F Goossens; C H Dragonetti; M M Mareel; M J De Brabander
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

View more
  3 in total

Review 1.  Cytoskeleton of apicomplexan parasites.

Authors:  Naomi S Morrissette; L David Sibley
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

2.  Effects of microtubule inhibitors on protein synthesis in Plasmodium falciparum.

Authors:  A Bell; B Wernli; R M Franklin
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

3.  Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasites.

Authors:  Fabrizio P L'abbate; Ronel Müller; Roxanne Openshaw; Jill M Combrinck; Katherine A de Villiers; Roger Hunter; Timothy J Egan
Journal:  Eur J Med Chem       Date:  2018-09-28       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.